FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

765509006: Product containing precisely carbidopa (as carbidopa monohydrate) 50 milligram and levodopa 200 milligram/1 each prolonged-release oral tablet (clinical drug)

    Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 31-Jul 2021. Module: SNOMED CT core module

    Descriptions:

    Id Description Lang Type Status Case? Module
    3674197013 Product containing precisely carbidopa (as carbidopa monohydrate) 50 milligram and levodopa 200 milligram/1 each prolonged-release oral tablet (clinical drug) en Fully specified name Active Entire term case insensitive SNOMED CT core module
    3674199011 Carbidopa (as carbidopa monohydrate) 50 mg and levodopa 200 mg prolonged-release oral tablet en Synonym Active Entire term case insensitive SNOMED CT core module

    0 descendants.

    Expanded Value Set

    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    Product containing precisely carbidopa (as carbidopa monohydrate) 50 milligram and levodopa 200 milligram/1 each prolonged-release oral tablet Has manufactured dose form Prolonged-release oral tablet false Inferred relationship Existential restriction modifier
    Product containing precisely carbidopa (as carbidopa monohydrate) 50 milligram and levodopa 200 milligram/1 each prolonged-release oral tablet Is a Product containing carbidopa and levodopa in oral dose form (medicinal product form) false Inferred relationship Existential restriction modifier
    Product containing precisely carbidopa (as carbidopa monohydrate) 50 milligram and levodopa 200 milligram/1 each prolonged-release oral tablet Has presentation strength denominator value 1 false Inferred relationship Existential restriction modifier 2
    Product containing precisely carbidopa (as carbidopa monohydrate) 50 milligram and levodopa 200 milligram/1 each prolonged-release oral tablet Has presentation strength numerator value 50 false Inferred relationship Existential restriction modifier 1
    Product containing precisely carbidopa (as carbidopa monohydrate) 50 milligram and levodopa 200 milligram/1 each prolonged-release oral tablet Has presentation strength denominator value 1 false Inferred relationship Existential restriction modifier 1
    Product containing precisely carbidopa (as carbidopa monohydrate) 50 milligram and levodopa 200 milligram/1 each prolonged-release oral tablet Has presentation strength denominator unit Tablet false Inferred relationship Existential restriction modifier 2
    Product containing precisely carbidopa (as carbidopa monohydrate) 50 milligram and levodopa 200 milligram/1 each prolonged-release oral tablet Has precise active ingredient Carbidopa monohydrate false Inferred relationship Existential restriction modifier 1
    Product containing precisely carbidopa (as carbidopa monohydrate) 50 milligram and levodopa 200 milligram/1 each prolonged-release oral tablet Has basis of strength substance Levodopa false Inferred relationship Existential restriction modifier 2
    Product containing precisely carbidopa (as carbidopa monohydrate) 50 milligram and levodopa 200 milligram/1 each prolonged-release oral tablet Has presentation strength numerator unit milligram false Inferred relationship Existential restriction modifier 2
    Product containing precisely carbidopa (as carbidopa monohydrate) 50 milligram and levodopa 200 milligram/1 each prolonged-release oral tablet Has presentation strength numerator value 200 false Inferred relationship Existential restriction modifier 2
    Product containing precisely carbidopa (as carbidopa monohydrate) 50 milligram and levodopa 200 milligram/1 each prolonged-release oral tablet Has precise active ingredient Levodopa false Inferred relationship Existential restriction modifier 2
    Product containing precisely carbidopa (as carbidopa monohydrate) 50 milligram and levodopa 200 milligram/1 each prolonged-release oral tablet Has unit of presentation Tablet false Inferred relationship Existential restriction modifier
    Product containing precisely carbidopa (as carbidopa monohydrate) 50 milligram and levodopa 200 milligram/1 each prolonged-release oral tablet Has presentation strength numerator unit milligram false Inferred relationship Existential restriction modifier 1
    Product containing precisely carbidopa (as carbidopa monohydrate) 50 milligram and levodopa 200 milligram/1 each prolonged-release oral tablet Has basis of strength substance Carbidopa false Inferred relationship Existential restriction modifier 1
    Product containing precisely carbidopa (as carbidopa monohydrate) 50 milligram and levodopa 200 milligram/1 each prolonged-release oral tablet Has presentation strength denominator unit Tablet false Inferred relationship Existential restriction modifier 1
    Product containing precisely carbidopa (as carbidopa monohydrate) 50 milligram and levodopa 200 milligram/1 each prolonged-release oral tablet Count of base of active ingredient 2 false Inferred relationship Existential restriction modifier
    Product containing precisely carbidopa (as carbidopa monohydrate) 50 milligram and levodopa 200 milligram/1 each prolonged-release oral tablet Is a Product containing only carbidopa and levodopa in oral dose form (medicinal product form) false Inferred relationship Existential restriction modifier
    Product containing precisely carbidopa (as carbidopa monohydrate) 50 milligram and levodopa 200 milligram/1 each prolonged-release oral tablet Plays role Antiparkinson therapeutic role false Inferred relationship Existential restriction modifier
    Inbound Relationships Type Active Source Characteristic Refinability Group

    This concept is not in any reference sets

    Back to Start